Friday Mar 7
Indianapolis Business News
IU prof DiMarchi to join Inventors Hall of Fame
Indiana University says one of its faculty members will be inducted into National Inventors Hall of Fame.
Indiana University professor to be honoured for his work on diabetes drug
It says distinguished professor of chemistry Richard DiMarchi is being honoured for his work on the drug Humalog, a synthetic analogue of the human hormone glucagon that has been used by millions around the world to address the complications of diabetes.
The Motley Fool
Is This Drug Enough To Revive Hope in Eli Lilly's Pipeline?
AWARD-6 examined dulaglutide v. the maximum dosage of Victoza in 599 patients currently taking metformin.
Adocia Announces Preliminary Positive Clinical Results For Its...
Adocia announces today positive preliminary results for the first clinical trial on an innovative formulation combining insulin analog Glargine , Sanofi), the gold standard basal insulin, with a rapid-acting insulin analog, Lispro , Eli Lilly) using Adocia's BioChaperone technology.
Applied Clinical Trials
Lilly's Once-Weekly Dulaglutide Shows Non-Inferiority to Liraglutide...
In the AWARD-6 study, once-weekly dulaglutide 1.5 mg achieved the primary endpoint of non-inferiority to once-daily liraglutide 1.8 mg, as measured by the reduction of hemoglobin A1c from baseline at 26 weeks.
Biodel Announces Plans to Advance BIOD-531 Based on Positive Clinical Trial Results
Biodel Inc. today announced preliminary results from Study 3-150, a Phase 1 clinical trial comparing Biodel's proprietary insulin formulation, BIOD-531, to the marketed products Humulin R U-500 and Humalog Mix 75/25.